enow.com Web Search

Search results

1. Results from the WOW.Com Content Network

2. Fluticasone furoate - Wikipedia

   en.wikipedia.org/wiki/Fluticasone_furoate

   Fluticasone furoate, sold under the brand name Flonase Sensimist among others, is a corticosteroid for the treatment of non-allergic and allergic rhinitis administered by a nasal spray. [9] It is also available as an inhaled corticosteroid to help prevent and control symptoms of asthma .

3. Fluticasone propionate - Wikipedia

   en.wikipedia.org/wiki/Fluticasone_propionate

   Fluticasone propionate, sold under the brand names Flovent and Flonase among others, is a glucocorticoid steroid medication. [8] When inhaled it is used for the long term management of asthma and COPD. [8] In the nose it is used for hay fever and nasal polyps. [9] [10] It can also be used for mouth ulcers. [11] It works by decreasing inflammation.

4. Parents search for Flovent alternatives as childhood asthma ...

   www.aol.com/parents-search-flovent-alternatives...

   Flovent, one of the most commonly prescribed childhood asthma inhalers, is no longer being manufactured in the United States.. This preventative medication is usually taken every day to help keep ...

5. Fluticasone - Wikipedia

   en.wikipedia.org/wiki/Fluticasone

   Fluticasone is a manufactured glucocorticoid used to treat nasal congestion. [1] [2] [3] [4] [5] Both the esters, fluticasone propionate (sold as Flovent) and ...

6. 11-Year-Old Girl Who Tried to Save Boy, 12, After He Fell ...

   www.aol.com/11-old-girl-tried-save-161900960.html

   Dec. 8, police officers and firefighters responded to the incident at around 4:30 p.m., and the 12-year-old boy's body was recovered from the water about three hours later.

7. Fluticasone furoate/vilanterol - Wikipedia

   en.wikipedia.org/wiki/Fluticasone_furoate/vilanterol

   The FDA label was changed in April 2015, to add an indication for a once-daily treatment of asthma in people aged 18 years of age and older. [3] The exclusivity for a new product ended in May 2016, in the United States, and the exclusivity on the indication for asthma expired on 30 April 2018. [ 11 ]